Lv1
35 积分 2022-01-12 加入
Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial
1个月前
已完结
Pembrolizumab versus chemotherapy in microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer: 5-year follow-up from the randomized phase III KEYNOTE-177 study
1个月前
已完结
Oxaliplatin-induced immune mediated thrombocytopenia
2个月前
已完结
[Updates in the 5(th) edition of WHO classification of tumours of the breast]
2个月前
已完结
[Expert consensus on diagnosis and treatment of malignant pleural effusion caused by lung cancer]
6个月前
已完结
The treatment of advanced melanoma: Current approaches and new challenges
7个月前
已完结
Tislelizumab Plus Chemotherapy as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC (RATIONALE 304): A Randomized Phase 3 Trial
7个月前
已完结
Prediction of Creatinine Clearance from Serum Creatinine
9个月前
已完结
Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial
9个月前
已完结
皖公网安备34019202002308
